Cardlytics, Inc. (CDLX)

Cardlytics Statistics

Total Valuation

Cardlytics has a market cap or net worth of $189.57 million. The enterprise value is $344.52 million.

Market Cap	189.57M
Enterprise Value	344.52M

Important Dates

The last earnings date was Wednesday, November 6, 2024, after market close.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

Cardlytics has 50.82 million shares outstanding. The number of shares has increased by 30.07% in one year.

Current Share Class	50.82M
Shares Outstanding	50.82M
Shares Change (YoY)	+30.07%
Shares Change (QoQ)	+1.98%
Owned by Insiders (%)	2.30%
Owned by Institutions (%)	49.60%
Float	43.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.58
Forward PS	0.70
PB Ratio	2.69
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.17
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.18, with a Debt / Equity ratio of 3.18.

Current Ratio	1.18
Quick Ratio	1.13
Debt / Equity	3.18
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.65

Financial Efficiency

Return on equity (ROE) is -186.12% and return on invested capital (ROIC) is -10.11%.

Return on Equity (ROE)	-186.12%
Return on Assets (ROA)	-7.62%
Return on Capital (ROIC)	-10.11%
Revenue Per Employee	$676,194
Profits Per Employee	-$632,606
Employee Count	434
Asset Turnover	0.57
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -59.98% in the last 52 weeks. The beta is 1.53, so Cardlytics's price volatility has been higher than the market average.

Beta (5Y)	1.53
52-Week Price Change	-59.98%
50-Day Moving Average	3.94
200-Day Moving Average	7.16
Relative Strength Index (RSI)	47.17
Average Volume (20 Days)	742,691

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cardlytics had revenue of $293.47 million and -$274.55 million in losses. Loss per share was -$6.04.

Revenue	293.47M
Gross Profit	127.65M
Operating Income	-63.05M
Pretax Income	-153.33M
Net Income	-274.55M
EBITDA	-36.60M
EBIT	-63.05M
Loss Per Share	-$6.04

Balance Sheet

The company has $66.99 million in cash and $221.95 million in debt, giving a net cash position of -$154.96 million or -$3.05 per share.

Cash & Cash Equivalents	66.99M
Total Debt	221.95M
Net Cash	-154.96M
Net Cash Per Share	-$3.05
Equity (Book Value)	69.70M
Book Value Per Share	1.38
Working Capital	27.42M

Cash Flow

In the last 12 months, operating cash flow was -$8.87 million and capital expenditures -$1.71 million, giving a free cash flow of -$10.58 million.

Operating Cash Flow	-8.87M
Capital Expenditures	-1.71M
Free Cash Flow	-10.58M
FCF Per Share	-$0.21

Margins

Gross margin is 43.50%, with operating and profit margins of -21.48% and -93.55%.

Gross Margin	43.50%
Operating Margin	-21.48%
Pretax Margin	-93.55%
Profit Margin	-93.55%
EBITDA Margin	-12.47%
EBIT Margin	-21.48%
FCF Margin	n/a

Dividends & Yields

Cardlytics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.07%
Shareholder Yield	-30.07%
Earnings Yield	-144.83%
FCF Yield	-5.58%

Analyst Forecast

The average price target for Cardlytics is $5.90, which is 58.18% higher than the current price. The consensus rating is "Hold".

Price Target	$5.90
Price Target Difference	58.18%
Analyst Consensus	Hold
Analyst Count	6
Revenue Growth Forecast (5Y)	1.50%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cardlytics has an Altman Z-Score of -3.51 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.51
Piotroski F-Score	5